Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease. | Clin Exp Immunol;108(1): 42-6, 1997 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease.

Giacomelli, R; Cipriani, P; Lattanzio, R; Di Franco, M; Locanto, M; Parzanese, I; Passacantando, A; Ciocci, A; Tonietti, G.

Affiliation

Giacomelli R; Clinica Medica, University of L'Aquila, Italy.

Clin Exp Immunol ; 108(1): 42-6, 1997 Apr.

Article in En | MEDLINE | ID: mdl-9097909

Subject(s)

Ki-1 Antigen/blood; Scleroderma, Systemic/immunology; Adult; Aged; Cells, Cultured; Humans; Immunophenotyping; Leukocytes, Mononuclear/immunology; Middle Aged; Scleroderma, Systemic/blood

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Ki-1 Antigen Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Clin Exp Immunol Year: 1997 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Ki-1 Antigen Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Clin Exp Immunol Year: 1997 Document type: Article